{
  "retracted": false,
  "timestamp": 1588550400000,
  "updates": [
    {
      "timestamp": 1588669856107,
      "identifier": {
        "doi": "10.1136/ijgc-2019-001012corr1"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1136/ijgc-2019-001012"
  },
  "journal": "International Journal of Gynecologic Cancer",
  "publisher": "BMJ",
  "title": "Correction: Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancer"
}
